Literature DB >> 20682149

Guidance on medical eligibility criteria for contraceptive use: identification of research gaps.

Suzanne G Folger1, Kathryn M Curtis, Naomi K Tepper, Mary E Gaffield, Polly A Marchbanks.   

Abstract

Mesh：

Year:  2010        PMID： 20682149     DOI： 10.1016/j.contraception.2010.02.015

Source DB:  PubMed          Journal:  Contraception        ISSN： 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  7 in total

1.  Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer.

Authors:  Sarah Averbach; Michael J Silverberg; Wendy Leyden; Karen Smith-McCune; Tina Raine-Bennett; George F Sawaya
Journal:  Contraception       Date:  2018-04-17       Impact factor: 3.375

Review 2.  A systematic review of early postpartum medroxyprogesterone receipt and early breastfeeding cessation: evaluating the methodological rigor of the evidence.

Authors:  Elizabeth A Brownell; I Diana Fernandez; Cynthia R Howard; Susan G Fisher; Sharon R Ternullo; Ryan J J Buckley; Ann M Dozier
Journal:  Breastfeed Med       Date:  2011-11-15       Impact factor: 1.817

Review 3.  Putting risk into perspective: the US medical eligibility criteria for contraceptive use.

Authors:  Kathryn M Curtis; Naomi K Tepper; Polly A Marchbanks
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

4.  The effect of immediate postpartum depot medroxyprogesterone on early breastfeeding cessation.

Authors:  Elizabeth A Brownell; I Diana Fernandez; Susan G Fisher; Cynthia R Howard; Sharon R Ternullo; Ruth A Lawrence; Joseph W Duckett; Ann M Dozier
Journal:  Contraception       Date:  2012-11-12       Impact factor: 3.375

5.  Placement of Levonorgestrel Intrauterine Device at the Time of Cesarean Delivery and the Effect on Breastfeeding Duration.

Authors:  Erika E Levi; Molly K Findley; Karina Avila; Amy G Bryant
Journal:  Breastfeed Med       Date:  2018-10-30       Impact factor: 1.817

6.  Effect of protease inhibitors on steady-state pharmacokinetics of oral norethindrone contraception in HIV-infected women.

Authors:  Jessica Atrio; Frank Z Stanczyk; Michael Neely; Ganesh Cherala; Andrea Kovacs; Daniel R Mishell
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731

7.  Condom and oral contraceptive use and risk of cervical intraepithelial neoplasia in Australian women.

Authors:  Hui Jun Chih; Andy H Lee; Linda Colville; Daniel Xu; Colin W Binns
Journal:  J Gynecol Oncol       Date:  2014-07-03       Impact factor: 4.401
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.